This is a developing news story. Please check back soon for updates. Bausch + Lomb will return its enVista IOLs to market after identifying the event that led to a voluntary recall, according to a ...

Bausch + Lomb addresses recent IOL recall, ensuring safety with enhanced protocols and returning enVista lenses to market ...

Bausch + Lomb announced today that it intends to bring its recently recalled enVista intraocular lenses (IOLs) back to the ...

Bausch + Lomb will return its enVista intraocular lenses to market following a voluntary recall in March after discovering they had certain production and material issues.

Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, today announced it has identified the event that led to its ...

The global market for scleral lenses is witnessing a significant upswing, with a projected compound annual growth rate (CAGR) of 6.3% over the next decade. According to a recent report by Future ...

A group of teenagers retreat to the woods to process their feelings in playwright Eliya Smith’s thoughtful and elliptical ...

We recently published a list of 13 Best Canadian Penny Stocks to Invest in Now In this article, we are going to take a look ...

Bausch Health has launched a shareholder rights plan—also known as a poison pill defense—designed to prevent any one entity ...

After enacting a “poison pill” defense to protect itself from unwanted potential buyers, Bausch Health has spotted a major ...

The city of Paso Robles is suing its own councilmember in what may be a “first of its kind” lawsuit to compel Chris Bausch to ...

In suing its own sitting councilmember and echoing The Tribune’s lawsuit, the city has accused Chris Bausch of willfully ...